JEFFERSON CITY, Mo. (AP) — The Missouri Senate has given first-round approval to legislation that could lower treatment costs for some cancer patients.
The measure endorsed Tuesday would let insurance companies charge patients only $75 more per month for chemotherapy pills than traditional intravenous chemotherapy treatments.
Patients are often charged much more for oral chemotherapy because it is handled as a pharmacy benefit. Intravenous treatments often only cost the standard co-payment for an office visit.